At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II Study of Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers
In Brief
A Phase 2 clinical trial evaluating Cisplatin, Gemcitabine Hydrochloride, and 2 other interventions for Stage III Intrahepatic Cholangiocarcinoma AJCC v7 and 8 related conditions. Completed, enrolled 62 participants across 3 sites.
Detailed Summary
This phase II trial studies how well gemcitabine hydrochloride, cisplatin, and nab-paclitaxel (paclitaxel albumin-stabilized nanoparticle formulation) work in treating patients with biliary cancers (which includes the gallbladder and bile ducts inside and outside the liver) that have spread to other places in the body and usually cannot be cured or controlled with treatment. Drugs used in chemotherapy, such as gemcitabine hydrochloride, cisplatin, and paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
Study Details
Timeline
Interventions
Given IV
Given IV
Correlative studies
Given IV